Literature DB >> 3674600

Perianal suppuration: results of treatment.

R C Doberneck1.   

Abstract

Perianal suppuration (PAS) is a common surgical problem that is frequently treated inadequately. A series of 101 patients with PAS was reviewed. Thirty-six patients had a history of PAS. Fifty patients had drainage of a perianal abscess; six patients developed fistulas in ano and in two recurrent abscess developed (total, 16%). Thirty-six patients had fistulotomy for established anal fistula: three patients (8%) had recurrent fistulas. Fifteen patients had single-stage drainage of abscess and fistulotomy, and none had recurrent or residual PAS. All patients ultimately achieved healing. These results illustrate the fact that satisfactory results in the treatment of PAS can be obtained by surgeons if established principles of treatment are observed.

Entities:  

Mesh:

Year:  1987        PMID: 3674600

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  Needle aspiration treatment vs. incision of acute simple perianal abscess: randomized controlled study.

Authors:  Karam Matlub Sørensen; Sören Möller; Niels Qvist
Journal:  Int J Colorectal Dis       Date:  2021-01-15       Impact factor: 2.571

Review 2.  Treatment-Based Three-Dimensional Classification and Management of Anorectal Infections.

Authors:  A E Ortega; K G Cologne; J Shin; S W Lee; G T Ault
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

3.  Ethanol consumption inhibits TFH cell responses and the development of autoimmune arthritis.

Authors:  Vugar Azizov; Katharina Dietel; Franziska Steffen; Kerstin Dürholz; Julia Meidenbauer; Sébastien Lucas; Michael Frech; Yasunori Omata; Narges Tajik; Lisa Knipfer; Anne Kolenbrander; Silvia Seubert; Dennis Lapuente; Maria V Sokolova; Jörg Hofmann; Matthias Tenbusch; Andreas Ramming; Ulrike Steffen; Falk Nimmerjahn; Ralf Linker; Stefan Wirtz; Martin Herrmann; Vladimir Temchura; Kerstin Sarter; Georg Schett; Mario M Zaiss
Journal:  Nat Commun       Date:  2020-04-24       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.